Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ChemoMetec A/S Issues FY 2013/2014 Financial Guidance; Proposes No Dividend for FY 2012/2013


Wednesday, 18 Sep 2013 02:30am EDT 

ChemoMetec A/S announced that it expects to report fiscal year 2013/2014 revenue in a range of between DKK 43 million and DKK 45 million and fiscal year 2013/2014 operating profit (EBITDA) in a range of between DKK 6 million and DKK 8 million. The Company also announced that its Board of Directors proposes to the Annual General Meeting that no dividend be paid for fiscal year 2012/2013. 

Company Quote

3.85
0.02 +0.52%
31 Jul 2014